ExpreS2ion announces full exercise of 2019 warrant program
Hørsholm, Denmark, September 7, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces that 308,268 warrants held by employees under the 2019 Warrant Program (“TO2”) have been fully exercised, providing ExpreS2ion SEK 1,482,769. The exercise has increased the number of shares by 308,268 from 37,298,528 to 37,606,796. All 612,084 TO2 warrants have now been exercised, providing ExpreS2ion in total SEK 2,944,124.At an Extra General Meeting in ExpreS[2]ion held on May 23, 2019, it was resolved to issue warrants as part of an incentive program for employees (“the 2019 Warrant